Perspective Therapeutics, Inc.
Filed with the SEC on · accession 0001193125-26-453712
CATX filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. Perspective Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures. The stock moved +1.9% by the first close after the filing.
Perspective Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures. The filing includes details on cash and cash equivalents, investments, and operating expenses.
Close before
$0.84
Nov 6, 2026
First close after
+1.86%
$0.86
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CATX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CATX?
Click hereCATX filed a 10-Q (SEC filing). Perspective Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures. The filing includes details on cash and cash equivalents, investments, and operating expenses.
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
CATX closed at $0.84 before the filing and $0.86 on Nov 9, 2026 (+1.86%).
Get alerts when CATX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days